MIT Tech Review: AI Accelerates Drug Design and Autonomous Discovery Labs
nordicinst · x · 2026-07-23
MIT Technology Review explores the deep application of AI in biotechnology. AI is significantly accelerating drug design, targeting complex multi-disease biology, and helping build autonomous discovery labs. European giants are pushing frontier biotech, proving machines can help cure humans while keeping human experts in the loop.
More from Research
- AI slop is already clogging PR review and weakening the credit system behind science — rbhar90 · 2026-07-27
- ICML 2026 oral paper replication scores stay middling after a stricter re-scoring — profjamesevans · 2026-07-27
- Long-running agents will need immutable event logs, this thread argues — sebpaquet · 2026-07-27
- Seed IQ navigates Doom II, prompting questions about benchmarks beyond ARC-AGI — Fit_Transition8824 · 2026-07-27
- Agentic Data Science in Practice: Agents Write Code but Answer Wrong Questions — hugobowne · 2026-07-27
- A concise canon of foundational papers in ML, systems, NLP, speech, and audio — deliprao · 2026-07-27